{"id":"https://openalex.org/W4361827155","doi":"https://doi.org/10.1158/0008-5472.c.6513486.v1","title":"Data from Cell Line\u2013Specific Network Models of ER+ Breast Cancer Identify Potential PI3K\u03b1 Inhibitor Resistance Mechanisms and Drug Combinations","display_name":"Data from Cell Line\u2013Specific Network Models of ER+ Breast Cancer Identify Potential PI3K\u03b1 Inhibitor Resistance Mechanisms and Drug Combinations","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361827155","doi":"https://doi.org/10.1158/0008-5472.c.6513486.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6513486.v1","doi":"https://doi.org/10.1158/0008-5472.c.6513486.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6513486.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6513486.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042886213","display_name":"Jorge G\u00f3mez Tejeda Za\u00f1udo","orcid":"https://orcid.org/0000-0002-1092-0068","observed_orcids":["https://orcid.org/0000-0002-1092-0068"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210086405","display_name":"National Institute of Biological Sciences, Beijing","ror":"https://ror.org/00wksha49","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210086405"]},{"id":"https://openalex.org/I4210155646","display_name":"Bluebird Bio (United States)","ror":"https://ror.org/04vaq9436","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155646"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"Jorge G\u00f3mez Tejeda Za\u00f1udo","raw_affiliation_strings":["Bluebird bio, Cambridge, Massachusetts","Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142","National Institute of Biological Sciences (NIBS), Beijing, China"],"raw_orcid":"https://orcid.org/0000-0002-1092-0068","affiliations":[{"raw_affiliation_string":"Bluebird bio, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210155646"]},{"raw_affiliation_string":"Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"National Institute of Biological Sciences (NIBS), Beijing, China","institution_ids":["https://openalex.org/I4210086405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011630205","display_name":"Pingping Mao","orcid":"https://orcid.org/0009-0002-6608-6559","observed_orcids":["https://orcid.org/0009-0002-6608-6559"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pingping Mao","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067967688","display_name":"Clara Alcon","orcid":"https://orcid.org/0000-0003-3243-9440","observed_orcids":["https://orcid.org/0000-0003-3243-9440"]},"institutions":[{"id":"https://openalex.org/I4210132884","display_name":"Barcelona Institute of Science and Technology","ror":"https://ror.org/03kpps236","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210132884"]},{"id":"https://openalex.org/I4210147769","display_name":"Institute for Bioengineering of Catalonia","ror":"https://ror.org/056h71x09","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210147769","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Clara Alcon","raw_affiliation_strings":["Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-3243-9440","affiliations":[{"raw_affiliation_string":"Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain","institution_ids":["https://openalex.org/I4210132884","https://openalex.org/I4210147769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020013190","display_name":"Kailey J. Kowalski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kailey Kowalski","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055952938","display_name":"Gabriela N. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela N. Johnson","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001090073","display_name":"Guotai Xu","orcid":"https://orcid.org/0000-0001-5265-3407","observed_orcids":["https://orcid.org/0000-0001-5265-3407"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guotai Xu","raw_affiliation_strings":["Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York","Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose Baselga","raw_affiliation_strings":["Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York","Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002819777","display_name":"Maurizio Scaltriti","orcid":"https://orcid.org/0000-0002-5522-1447","observed_orcids":["https://orcid.org/0000-0002-5522-1447"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maurizio Scaltriti","raw_affiliation_strings":["Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York","Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":"https://orcid.org/0000-0002-5522-1447","affiliations":[{"raw_affiliation_string":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022857112","display_name":"Anthony G. Letai","orcid":"https://orcid.org/0000-0002-1993-9013","observed_orcids":["https://orcid.org/0000-0002-1993-9013"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Letai","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":"https://orcid.org/0000-0002-1993-9013","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009011885","display_name":"Joan Montero","orcid":"https://orcid.org/0000-0002-9192-4836","observed_orcids":["https://orcid.org/0000-0002-9192-4836"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210132884","display_name":"Barcelona Institute of Science and Technology","ror":"https://ror.org/03kpps236","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210132884"]},{"id":"https://openalex.org/I4210147769","display_name":"Institute for Bioengineering of Catalonia","ror":"https://ror.org/056h71x09","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210147769","https://openalex.org/I4387153040"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Joan Montero","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-9192-4836","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain","institution_ids":["https://openalex.org/I4210132884","https://openalex.org/I4210147769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012905268","display_name":"R\u00e9ka Albert","orcid":"https://orcid.org/0000-0002-9485-0828","observed_orcids":["https://orcid.org/0000-0002-9485-0828"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R\u00e9ka Albert","raw_affiliation_strings":["Department of Biology, The Pennsylvania State University, Pennsylvania","Department of Physics, The Pennsylvania State University, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0002-9485-0828","affiliations":[{"raw_affiliation_string":"Department of Biology, The Pennsylvania State University, Pennsylvania","institution_ids":["https://openalex.org/I130769515"]},{"raw_affiliation_string":"Department of Physics, The Pennsylvania State University, Pennsylvania","institution_ids":["https://openalex.org/I130769515"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068721624","display_name":"Nikhil Wagle","orcid":"https://orcid.org/0000-0003-3332-9438","observed_orcids":["https://orcid.org/0000-0003-3332-9438"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil Wagle","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I107606265"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8370000123977661},{"id":"https://openalex.org/keywords/pi3kalpha-inhibitor","display_name":"PI3K\u03b1 inhibitor","score":0.8209999799728394},{"id":"https://openalex.org/keywords/alpelisib","display_name":"alpelisib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9269999861717224},{"id":"https://openalex.org/keywords/drug-resistance-mechanisms","display_name":"drug resistance mechanisms","score":0.9319999814033508},{"id":"https://openalex.org/keywords/drug-combination-prediction","display_name":"drug combination prediction","score":0.6549999713897705},{"id":"https://openalex.org/keywords/bh3-mimetics","display_name":"BH3 mimetics","score":0.9589999914169312},{"id":"https://openalex.org/keywords/mcl-1-inhibitors","display_name":"Mcl-1 inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.843999981880188}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5840058922767639},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4934879541397095},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4914757013320923},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4550905227661133},{"id":"https://openalex.org/C109541995","wikidata":"https://www.wikidata.org/wiki/Q1881253","display_name":"MCF-7","level":5,"score":0.4449959993362427},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.44196322560310364},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.439456969499588},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.42087388038635254},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2880900800228119},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.277130126953125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22123974561691284},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.17922788858413696},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.15386143326759338},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.12459307909011841},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10835063457489014}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6513486.v1","doi":"https://doi.org/10.1158/0008-5472.c.6513486.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6513486.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6513486.v1","doi":"https://doi.org/10.1158/0008-5472.c.6513486.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6513486.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2068782480","display_name":"Collaborative Research: Rational Design of Anticancer Drug Combinations using Dynamic Multidimensional Theory","funder_award_id":"1545839","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"},{"id":"https://openalex.org/G2888295325","display_name":null,"funder_award_id":"D2015-039","funder_id":"https://openalex.org/F4320332898","funder_display_name":"Stand Up To Cancer"},{"id":"https://openalex.org/G3603220033","display_name":null,"funder_award_id":"D2015-039","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"},{"id":"https://openalex.org/G5263746854","display_name":null,"funder_award_id":"D2015-039","funder_id":"https://openalex.org/F4320306536","funder_display_name":"V Foundation for Cancer Research"},{"id":"https://openalex.org/G7085905232","display_name":null,"funder_award_id":"PHY 1545832","funder_id":"https://openalex.org/F4320332898","funder_display_name":"Stand Up To Cancer"},{"id":"https://openalex.org/G7995573518","display_name":"Collaborative Research: Rational Design of Anticancer Drug Combinations using Dynamic Multidimensional Theory","funder_award_id":"1545832","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"},{"id":"https://openalex.org/G8210239791","display_name":null,"funder_award_id":"D2015-037","funder_id":"https://openalex.org/F4320332898","funder_display_name":"Stand Up To Cancer"},{"id":"https://openalex.org/G8394550714","display_name":"Collaborative Research: Rational Design of Anticancer Drug Combinations using Dynamic Multidimensional Theory","funder_award_id":"1545853","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320306536","display_name":"V Foundation for Cancer Research","ror":"https://ror.org/00kbbk236"},{"id":"https://openalex.org/F4320310210","display_name":"Fundaci\u00f3n Cellex","ror":"https://ror.org/019dmpq73"},{"id":"https://openalex.org/F4320332898","display_name":"Stand Up To Cancer","ror":"https://ror.org/01dmpb598"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W631732704","https://openalex.org/W1422650632","https://openalex.org/W1509669696","https://openalex.org/W1968852924","https://openalex.org/W1975570973","https://openalex.org/W1978221635","https://openalex.org/W1981517713","https://openalex.org/W1996413533","https://openalex.org/W2004280628","https://openalex.org/W2017187984","https://openalex.org/W2037720820","https://openalex.org/W2057366353","https://openalex.org/W2071463092","https://openalex.org/W2080534618","https://openalex.org/W2093917816","https://openalex.org/W2102004296","https://openalex.org/W2104036704","https://openalex.org/W2108541764","https://openalex.org/W2122624068","https://openalex.org/W2155228605","https://openalex.org/W2156918228","https://openalex.org/W2165056381","https://openalex.org/W2166525118","https://openalex.org/W2197234859","https://openalex.org/W2302083974","https://openalex.org/W2506550081","https://openalex.org/W2509236360","https://openalex.org/W2534349779","https://openalex.org/W2620174055","https://openalex.org/W2735132087","https://openalex.org/W2790669965","https://openalex.org/W2802173235","https://openalex.org/W2809999132","https://openalex.org/W2811244167","https://openalex.org/W2891700678","https://openalex.org/W2902000707","https://openalex.org/W2902257786","https://openalex.org/W2903599006","https://openalex.org/W2905887518","https://openalex.org/W2912260118","https://openalex.org/W2917986762","https://openalex.org/W2938305903","https://openalex.org/W2944727022","https://openalex.org/W2946317931","https://openalex.org/W2951789849","https://openalex.org/W2963655326","https://openalex.org/W2966546269","https://openalex.org/W2967392952","https://openalex.org/W2984379013","https://openalex.org/W2988773550","https://openalex.org/W2999841713","https://openalex.org/W3001475835","https://openalex.org/W3012647537","https://openalex.org/W3015152600","https://openalex.org/W3019012186","https://openalex.org/W3024684302","https://openalex.org/W3034207086"],"related_works":["https://openalex.org/W3178417187","https://openalex.org/W4247438624","https://openalex.org/W2951789849","https://openalex.org/W2887884259","https://openalex.org/W4402814697","https://openalex.org/W4391260845","https://openalex.org/W4396588103","https://openalex.org/W3138747497","https://openalex.org/W3154957625","https://openalex.org/W4383101267"],"abstract_inverted_index":{"Abstract":[0],"Durable":[1],"control":[2],"of":[3,49,88,105,140,148,154],"invasive":[4],"solid":[5],"tumors":[6],"necessitates":[7],"identifying":[8],"therapeutic":[9],"resistance":[10,81,159],"mechanisms":[11,160],"and":[12,29,51,90,124,151],"effective":[13],"drug":[14,30,142],"combinations.":[15],"In":[16],"this":[17,165],"work,":[18],"we":[19],"used":[20],"a":[21,78],"network-based":[22,131],"mathematical":[23,132,146],"model":[24],"to":[25,75,86,116,122,136],"identify":[26,158],"sensitivity":[27,74,85],"regulators":[28],"combinations":[31,87],"for":[32,54,161,168],"the":[33,69,103,118,138],"PI3K\u03b1":[34],"inhibitor":[35],"alpelisib":[36,50,89,123],"in":[37,61,171],"estrogen":[38],"receptor":[39],"positive":[40],"(ER+)":[41],"PIK3CA-mutant":[42],"breast":[43,63,172],"cancer.":[44,173],"The":[45],"model-predicted":[46],"efficacious":[47],"combination":[48],"BH3":[52,91,125],"mimetics,":[53],"example,":[55],"MCL1":[56],"inhibitors,":[57],"was":[58],"experimentally":[59],"validated":[60],"ER+":[62],"cancer":[64,141],"cell":[65,110],"lines.":[66],"Consistent":[67],"with":[68],"model,":[70],"FOXO3":[71],"downregulation":[72],"reduced":[73],"alpelisib,":[76],"revealing":[77],"novel":[79],"potential":[80],"mechanism.":[82],"Cell":[83],"line\u2013specific":[84,111],"mimetics":[92],"depended":[93],"on":[94],"which":[95],"BCL2":[96],"family":[97],"members":[98],"were":[99,114],"highly":[100],"expressed.":[101],"On":[102],"basis":[104],"these":[106],"results,":[107],"newly":[108],"developed":[109],"network":[112],"models":[113,133,147],"able":[115],"recapitulate":[117],"observed":[119],"differential":[120],"response":[121],"mimetics.":[126],"This":[127],"approach":[128],"illustrates":[129],"how":[130],"can":[134,157],"contribute":[135],"overcoming":[137],"challenge":[139],"resistance.":[143],"Significance:":[144],"Network-based":[145],"oncogenic":[149],"signaling":[150],"experimental":[152],"validation":[153],"its":[155],"predictions":[156],"targeted":[162],"therapies,":[163],"as":[164],"study":[166],"demonstrates":[167],"PI3K\u03b1-specific":[169],"inhibitors":[170]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-04-05T00:00:00"}